2Xin Huang1,Ding Guo Li1,Zhi Rong Wang1,Hong Shan Wei1,Ji Lin Cheng1,Yu Tao Zhan1,Xin Zhou1,Qin Fang Xu1,Xin Li2,Han Ming Lu1 1Xinhua Hospital, Shanghai Second Medical University, Shanghai 200092, China2Ninth Hospital. Shanghai Second Medical University, Shanghai 200011. China.Expression changes of activin A in the development of hepatic fibrosis[J].World Journal of Gastroenterology,2001,7(1):37-41. 被引量：12
3Qing He Nie Yong Qian Cheng Yu Mei Xie Yong Xing Zhou Yi Zhan Cao The Center of Infectious Disease Diagnosis and Treatment of PLA,Tangdu Hospital,Forth Military Medical University,Xi’an 710038,Shaanxi Province,ChinaDr,Qing He Nie graduated from Qinghai Medical College as a doctor in 1983,got master degree at Beijing 302 Army Hospital in 1993,got doctor degree at the Third Military Medical University in 1998,engaged in postdoctoral research at the Fourth Military Medical University from 1998 to 2000,now an associate professor,specialized in clinical and experimental research of infectious diseases,had more than 90 papers published,coauthor of ten books,first author of one book..Inhibiting effect of antisense oligonucleotides phosphorthioate on gene expression of TIMP-1 in rat liver fibrosis[J].World Journal of Gastroenterology,2001,7(3):363-369. 被引量：73
4Arthur MJ. Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis[J]. Am J Physiol Gastrointest Liver Physiol, 2000, 279:245- 249.
5Gabele E, Brenner DA. Rippe RA. Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell[J]. Front Biosci, 2003, 8: 69-77.
6Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF beta as major players and therapeutic targets[J]. J Cell Mol Med,2006, 10: 76-99.
